Okay. Thank you.
I have a question for Shannon. I realize that your role with the neurological charities is a new initiative. I think it was a year or two ago that it was embarked upon. I have two questions. One, how is the study going in terms of the $15 million investment to have that study of the rates of neurological disorders in Canada? Are there any initial signs that we're seeing about the growing prevalence of neurological disorders in Canada?
Secondly, a few of the witnesses we've heard in previous weeks have talked about some of the fascinating overlaps that we see in neurological disorders, where investments in one disease have resulted in new information being found on a different neurological disorder. Can you maybe expand for the committee why we can learn so much about these different diseases by investments in any of them?